Susceptibility Loci Reported in Genome-wide Association Studies Are Associated with Crohn's Disease in Canadian Children
Overview
Pharmacology
Authors
Affiliations
Background: Recent genome-wide association studies based on adult and paediatric populations have implicated >30 genes/loci as susceptibility loci for Crohn's disease (CD).
Aims: To investigate whether reported genes/loci were also associated with CD in Canadian children.
Design And Methods: A case-control design was implemented at three paediatric gastroenterology clinics in Canada. Children < or =18 years of age with a confirmed diagnosis of CD were recruited along with controls. Single nucleotide polymorphisms (SNPs) in five genome-wide association studies reported genes/loci were genotyped. Associations between individual SNPs and CD were examined.
Results: A total of 406 cases and 415 controls were studied. The mean (+/-s.d.) age of the cases was 12.3 (+/-3.2) years. Most cases were male (56.6%), had ileo-colonic disease (L3 +/- L4, 52.0%) and inflammatory behaviour (B1 +/- p, 86.9%) at diagnosis. Allelic association analysis (two-tailed) showed that three of the five targeted SNPs were significantly associated with overall susceptibility for CD (ZNF365, r10995271, P = 0.001; PTPN2, rs1893217, P = 0.005; STAT3, rs744166, P = 0.01). Associations with SNP rs4613763 in the PTGER4 locus were marginally nonsignificant (P = 0.07). The ZNF365 and STAT3 SNPs were predominantly associated with ileal disease with or without colonic involvement.
Conclusion: The identified susceptibility genes/loci for adult-onset CD also confer risk for paediatric-onset CD.
Innate immune response analysis in COVID-19 and kawasaki disease reveals MIS-C predictors.
Yang C, Huang Y, Chiang B J Formos Med Assoc. 2021; 121(3):623-632.
PMID: 34193364 PMC: 8214167. DOI: 10.1016/j.jfma.2021.06.009.
Wang C, Liu S, Kuang Y, Hu X, Fang X Oncol Lett. 2020; 20(4):85.
PMID: 32863918 PMC: 7436887. DOI: 10.3892/ol.2020.11946.
Wu P, Qian R, Hong C, Guo Y, Yu Y, Zhang G Medicine (Baltimore). 2020; 99(34):e19756.
PMID: 32846747 PMC: 7447366. DOI: 10.1097/MD.0000000000019756.
Samarani S, Mack D, Bernstein C, Iannello A, Debbeche O, Jantchou P PLoS One. 2019; 14(6):e0217767.
PMID: 31194766 PMC: 6563976. DOI: 10.1371/journal.pone.0217767.
Protein tyrosine phosphatase non-receptor type 2 and inflammatory bowel disease.
Spalinger M, McCole D, Rogler G, Scharl M World J Gastroenterol. 2016; 22(3):1034-44.
PMID: 26811645 PMC: 4716018. DOI: 10.3748/wjg.v22.i3.1034.